Panacea Life Sciences Holdings, Inc. (PLSH) stock
PLSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q1 FY2024, quarter ended Mar 31, 2024Last filing: 10-Q on May 6, 2024
$0.07+0.00 (+5.45%)
Close on Oct 19, 2026Market cap $1.15MP/E –Yield –
Panacea Life Sciences r&d expenses
Research and development expenses are spending on new products and technology.
Panacea Life Sciences's R&D Expenses for the twelve months ending Dec 31, 2020 was $0. For fiscal 2020 it was $0, down 100.0% from the year before. The highest annual figure on record is $369.34K in fiscal 2016.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $0 | -100.0% |
| FY2019 | Dec 31, 2019 | $22.10K | -92.6% |
| FY2018 | Dec 31, 2018 | $300.00K | -15.7% |
| FY2017 | Dec 31, 2017 | $356.08K | -3.6% |
| FY2016 | Dec 31, 2016 | $369.34K | +377.5% |
| FY2015 | Dec 31, 2015 | $77.34K | +32.6% |
| FY2014 | Dec 31, 2014 | $58.32K | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2020 | Dec 31, 2020 | $0 | -100.0% |
| Q3 FY2020 | Sep 30, 2020 | $0 | -100.0% |
| Q2 FY2020 | Jun 30, 2020 | $0 | -100.0% |
| Q1 FY2020 | Mar 31, 2020 | $0 | -100.0% |
| Q3 FY2019 | Sep 30, 2019 | $10.00K | -86.7% |
| Q2 FY2019 | Jun 30, 2019 | $10.00K | -86.7% |
| Q1 FY2019 | Mar 31, 2019 | $15.00K | -80.0% |
| Q4 FY2018 | Dec 31, 2018 | $75.00K | 0.0% |
| Q3 FY2018 | Sep 30, 2018 | $75.00K | -13.8% |
| Q2 FY2018 | Jun 30, 2018 | $75.00K | -29.2% |
| Q1 FY2018 | Mar 31, 2018 | $75.00K | -15.0% |
| Q4 FY2017 | Dec 31, 2017 | $75.00K | -50.9% |
| Q3 FY2017 | Sep 30, 2017 | $87.00K | -10.5% |
| Q2 FY2017 | Jun 30, 2017 | $105.87K | +14.3% |
| Q1 FY2017 | Mar 31, 2017 | $88.21K | +229.8% |
| Q4 FY2016 | Dec 31, 2016 | $152.70K | – |
| Q3 FY2016 | Sep 30, 2016 | $97.24K | – |
| Q2 FY2016 | Jun 30, 2016 | $92.65K | – |
| Q1 FY2016 | Mar 31, 2016 | $26.75K | – |
| Q4 FY2015 | Dec 31, 2015 | $0 | – |
| Q1 FY2015 | Mar 31, 2015 | $0 | – |
See a number that looks wrong?